Background.
Invasive fungal diseases are important causes of morbidity and mortality. Clarity and uniformity in defining these infections are important factors in improving the quality of clinical studies. A standard set of definitions strengthens the consistency and reproducibility of such studies.
Methods.
After the introduction of the original European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group definitions, advances in diagnostic technology and the recognition of areas in need of improvement led to a revision of this document. The revision process started with a meeting of participants in 2003, to decide on the process and to draft the proposal. This was followed by several rounds of consultation until a final draft was approved in 2005. This was made available for 6 months to allow public comment, and then the manuscript was prepared and approved.
Results.
The revised definitions retain the original classifications of “proven,” “probable,” and “possible” invasive fungal disease, but the definition of “probable” has been expanded, whereas the scope of the category “possible” has been diminished. The category of proven invasive fungal disease can apply to any patient, regardless of whether the patient is immunocompromised, whereas the probable and possible categories are proposed for immunocompromised patients only.
Conclusions.
These revised definitions of invasive fungal disease are intended to advance clinical and epidemiological research and may serve as a useful model for defining other infections in high‐risk patients.
Cited by
Laura Banov, Claudio Garanata, Carlo Dufour, Alberto Garaventa, Eddi Di Marco, Ilaria Caviglia, Cristina Moroni, Elio Castagnola. (2009) Pneumonia due to
Mycoplasma pneumoniae
in granulocytopenic children with cancer.
Pediatric Blood & Cancer 53:2, 240-242
Online publication date: 1-Sep-2009.
CrossRef Ronen Ben-Ami, Russell E Lewis, Dimitrios P Kontoyiannis. (2009) Invasive mould infections in the setting of hematopoietic cell transplantation: current trends and new challenges.
Current Opinion in Infectious Diseases 22:4, 376-384
Online publication date: 1-Sep-2009.
CrossRef Nikolaos G Almyroudis, Brahm H Segal. (2009) Prevention and treatment of invasive fungal diseases in neutropenic patients.
Current Opinion in Infectious Diseases 22:4, 385-393
Online publication date: 1-Sep-2009.
CrossRef Sheng‐Yuan Ruan, Jung‐Yien Chien, and Po‐Ren Hsueh. (2009) Invasive Trichosporonosis Caused by
Trichosporon asahii and Other Unusual
Trichosporon Species at a Medical Center in Taiwan.
Clinical Infectious Diseases 49:1, e11-e17
Online publication date: 1-Jul-2009.
C. H. Heath, M. A. Slavin, T. C. Sorrell, R. Handke, A. Harun, M. Phillips, Q. Nguyen, L. Delhaes, D. Ellis, W. Meyer, S. C. A. Chen, . (2009) Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of
Scedosporium aurantiacum
infection.
Clinical Microbiology and Infection Online publication date: 1-Jul-2009.
CrossRef Koki Ueda, Yasuhito Nannya, Keiki Kumano, Akira Hangaishi, Tsuyoshi Takahashi, Yoichi Imai, Mineo Kurokawa. (2009) Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders.
International Journal of Hematology 89:5, 592-599
Online publication date: 1-Jul-2009.
CrossRef R Olsson, J-E Juto, J Mattsson. (2009) Ethmoiditis-associated apex syndrome may result in temporary blindness after allo-SCT.
Bone Marrow Transplantation Online publication date: 4-Jun-2009.
CrossRef P. E. Verweij, J. Maertens. (2009) Moulds: diagnosis and treatment.
Journal of Antimicrobial Chemotherapy 63:Supplement 1, i31-i35
Online publication date: 1-Jun-2009.
CrossRef S. S. Weigt, R. M. Elashoff, C. Huang, A. Ardehali, A. L. Gregson, B. Kubak, M. C. Fishbein, R. Saggar, M. P. Keane, R. Saggar, J. P. Lynch III, D. A. Zisman, D. J. Ross, J. A. Belperio. (2009) Aspergillus Colonization of the Lung Allograft Is a Risk Factor for Bronchiolitis Obliterans Syndrome.
American Journal of Transplantation Online publication date: 1-Jun-2009.
CrossRef M. Ellis, B. Al-Ramadi, R. Bernsen, J. Kristensen, H. Alizadeh, U. Hedstrom. (2009) Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever.
Journal of Medical Microbiology 58:5, 606-615
Online publication date: 1-Jun-2009.
CrossRef J. E. Bennett. (2009) Management of mycoses in neutropenic patients: a brief history, 1960-2008.
Journal of Antimicrobial Chemotherapy 63:Supplement 1, i23-i26
Online publication date: 1-Jun-2009.
CrossRef Robin K. Avery. (2009) Aspergillosis in hematopoietic stem cell transplant recipients: Risk factors, prophylaxis, and treatment.
Current Infectious Disease Reports 11:3, 223-228
Online publication date: 1-Jun-2009.
CrossRef Johan Maertens, Wouter Meersseman, Pascal Van Bleyenbergh. (2009) New therapies for fungal pneumonia.
Current Opinion in Infectious Diseases 22:2, 183-190
Online publication date: 1-May-2009.
CrossRef P Zhang, A Song, Z Wang, S Feng, L Qiu, M Han. (2009) Hematopoietic SCT in patients with a history of invasive fungal infection.
Bone Marrow Transplantation 43:7, 533-537
Online publication date: 1-May-2009.
CrossRef Rishi Desai, Lawrence A. Ross, Jill A. Hoffman. (2009) The Role of Bronchoalveolar Lavage Galactomannan in the Diagnosis of Pediatric Invasive Aspergillosis.
The Pediatric Infectious Disease Journal 28:4, 283-286
Online publication date: 1-May-2009.
CrossRef H Hebart, L Klingspor, T Klingebiel, J Loeffler, J Tollemar, P Ljungman, H Wandt, K Schaefer-Eckart, H J Dornbusch, C Meisner, C Engel, N Stenger, T Mayer, O Ringden, H Einsele. (2009) A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT.
Bone Marrow Transplantation 43:7, 553-561
Online publication date: 1-May-2009.
CrossRef E Hardak, M Yigla, I Avivi, O Fruchter, H Sprecher, I Oren. (2009) Impact of PCR-based diagnosis of invasive pulmonary aspergillosis on clinical outcome.
Bone Marrow Transplantation Online publication date: 23-Apr-2009.
CrossRef Ronen Ben‐Ami, Russell E. Lewis, Issam I. Raad, and Dimitrios P. Kontoyiannis. (2009) Phaeohyphomycosis in a Tertiary Care Cancer Center.
Clinical Infectious Diseases 48:8, 1033-1041
Online publication date: 15-Apr-2009.
Daniel R. Kaul, James Riddell. (2009) Approach to the immunocompromised patient with pulmonary nodules.
Current Fungal Infection Reports 3:1, 45-54
Online publication date: 1-Apr-2009.
CrossRef C. León, F. Álvarez-Lerma, S. Ruiz-Santana, M. Á. León, J. Nolla, R. Jordá, P. Saavedra, M. Palomar, . (2009) Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study.
European Journal of Clinical Microbiology & Infectious Diseases 28:3, 233-242
Online publication date: 1-Apr-2009.
CrossRef Alison G. Freifeld. (2009) Real-time polymerase chain reaction testing for early detection of invasive aspergillosis in patients with febrile neutropenia.
Current Fungal Infection Reports 3:1, 1-3
Online publication date: 1-Apr-2009.
CrossRef G. Montenegro, S. Sanchez Puch, V. M. Jewtuchowicz, M. V. Pinoni, S. Relloso, E. Temporitti, C. A. Iovannitti, M. T. Mujica. (2009) Phenotypic and genotypic characterization of Aspergillus lentulus and Aspergillus fumigatus isolates in a patient with probable invasive aspergillosis.
Journal of Medical Microbiology 58:3, 391-395
Online publication date: 1-Apr-2009.
CrossRef Christina E. Barkauskas, John R. Perfect. (2009) Candida pneumonia: What we know and what we don’t.
Current Fungal Infection Reports 3:1, 21-31
Online publication date: 1-Apr-2009.
CrossRef Thomas R. Rogers, Susanna Frost. (2009) Newer antifungal agents for invasive fungal infections in patients with haematological malignancy.
British Journal of Haematology 144:5, 629-641
Online publication date: 1-Apr-2009.
CrossRef G. Maschmeyer, M. Sandherr. (2009) Infektionen in der Hämatologie und Onkologie.
Der Internist 50:2, 187-202
Online publication date: 1-Mar-2009.
CrossRef Fabio Forghieri, Giulio Rossi, Leonardo Potenza, Monica Morselli, Patrizia Barozzi, Daniela Vallerini, Massimino Messino, Fabio Rumpianesi, Monica Pecorari, Giuseppe Torelli, Mario Luppi. (2009) Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia.
American Journal of Hematology NA-NA
Online publication date: 1-Feb-2009.
CrossRef Shigenori Kusuki, Yoshiko Hashii, Hisao Yoshida, Sachiko Takizawa, Emiko Sato, Sadao Tokimasa, Hideaki Ohta, Keiichi Ozono. (2009) Antifungal prophylaxis with micafungin in patients treated for childhood cancer.
Pediatric Blood & Cancer n/a-n/a
Online publication date: 1-Feb-2009.
CrossRef Kyoung-Ho Song, Shinwon Lee, Hee-Chang Jang, Jae Hyun Jeon, Wan Beom Park, Kyoung Un Park, Sang-Won Park, Myoung-don Oh, Kang Won Choe. (2009) Diagnostic Usefulness of Galactomannan Assay for Invasive Aspergillosis.
Infection and Chemotherapy 41:2, 82
Online publication date: 1-Feb-2009.
CrossRef J. Peter Donnelly, Rosemary A. Barnes, Jurgen Loeffler. (2009) Challenges and progress in setting a standard for PCR for invasive aspergillosis.
Current Fungal Infection Reports 2:4, 232-236
Online publication date: 1-Jan-2009.
CrossRef Lennert Slobbe, Suzanne Polinder, Jeanette K. Doorduijn, Pieternella J. Lugtenburg, Abdelilah el Barzouhi, Ewout W. Steyerberg, and Bart J. A. Rijnders. (2008) Outcome and Medical Costs of Patients with Invasive Aspergillosis and Acute Myelogenous Leukemia–Myelodysplastic Syndrome Treated with Intensive Chemotherapy: An Observational Study.
Clinical Infectious Diseases 47:12, 1507-1512
Online publication date: 15-Dec-2008.
Johan Maertens, Griet Huysmans, Koen Theunissen. (2008) Early diagnosis and preemptive therapy of pulmonary mold infections in high-risk patients.
Current Infectious Disease Reports 10:6, 459-465
Online publication date: 1-Dec-2008.
CrossRef Valerio Del Bono, Małgorzata Mikulska, Claudio Viscoli. (2008) Invasive aspergillosis: diagnosis, prophylaxis and treatment.
Current Opinion in Hematology 15:6, 586-593
Online publication date: 1-Dec-2008.
CrossRef Shigeru Kohno. (2008)
Editorial Commentary: High Mortality in Invasive Aspergillosis: What We Need to Know for Determination of Poor Prognosis and Next Countermeasures.
Clinical Infectious Diseases 47:9, 1185-1187
Online publication date: 1-Nov-2008.
Johan Maertens, Jenny Bryan. (2008) Recent progress in the management of invasive fungal infections in hematopoietic stem cell transplant recipients.
Future Microbiology 3:5, 493-496
Online publication date: 1-Nov-2008.
CrossRef Brahm H. Segal, Raoul Herbrecht, David A. Stevens, Luis Ostrosky‐Zeichner, Jack Sobel, Claudio Viscoli, Thomas J. Walsh, Johan Maertens, Thomas F. Patterson, John R. Perfect, Bertrand Dupont, John R. Wingard, Thierry Calandra, Carol A. Kauffman, John R. Graybill, Lindsey R. Baden, Peter G. Pappas, John E. Bennett, Dimitrios P. Kontoyiannis, Catherine Cordonnier, Maria Anna Viviani, Jacques Bille, Nikolaos G. Almyroudis, L. Joseph Wheat, Wolfgang Graninger, Eric J. Bow, Steven M. Holland, Bart‐Jan Kullberg, William E. Dismukes, and Ben E. De Pauw. (2008) Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria.
Clinical Infectious Diseases 47:5, 674-683
Online publication date: 1-Sep-2008.
Maria J G T Rüping, Jörg J Vehreschild, Oliver A Cornely. (2008) Patients at High Risk of Invasive Fungal Infections.
Drugs 68:14, 1941-1962
Online publication date: 1-Feb-2008.
CrossRef